Brought to you by 
Boston Scientific buys Atritech
26 Jan 2011
Executive Summary
Boston Scientific Corp. has agreed to buy closely held atrial fibrillation (AF) device company Atritech Inc. for $100mm up front, plus up to $275mm in earn-outs for regulatory and revenue-based milestones over the next four years.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com